Shanghai Hile Bio-Technology Co., Ltd. (603718) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Hile Bio-Technology Co., Ltd.

Why is Shanghai Hile Bio-Technology Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 1.79%

The company has been able to generate a Return on Capital Employed (avg) of 1.79% signifying low profitability per unit of total capital (equity and debt)

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of -10.64% and Operating profit at 27.57% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 6.32% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -10.64% and Operating profit at 27.57% over the last 5 years

Negative results in Jun 26

NET SALES(9M) At CNY 174.02 MM has Grown at -14.6%
INTEREST(HY) At CNY 0.86 MM has Grown at 11.91%
PRE-TAX PROFIT(Q) At CNY 13.04 MM has Fallen at -88.07%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -55.43%, its profits have risen by 53.8% ; the PEG ratio of the company is 0.1
At the current price, the company has a high dividend yield of 2.8

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Hile Bio-Technology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai Hile Bio-Technology Co., Ltd.

-55.22%

-1.31

41.71%

China Shanghai Composite

3.23%

0.23

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-10.64%

EBIT Growth (5y)

27.57%

EBIT to Interest (avg)

6.96

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

0.17

Tax Ratio

53.62%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.98%

ROE (avg)

6.32%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.05

EV to EBIT

43.85

EV to EBITDA

30.60

EV to Capital Employed

2.61

EV to Sales

8.74

PEG Ratio

0.10

Dividend Yield

2.78%

ROCE (Latest)

5.96%

ROE (Latest)

37.48%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

NET PROFIT(9M)

Higher at CNY 317.67 MM

NET SALES(Q)

Highest at CNY 88.5 MM

OPERATING PROFIT(Q)

Highest at CNY 20.53 MM

-21What is not working for the Company

NET SALES(9M)

At CNY 174.02 MM has Grown at -14.6%

INTEREST(HY)

At CNY 0.86 MM has Grown at 11.91%

PRE-TAX PROFIT(Q)

At CNY 13.04 MM has Fallen at -88.07%

NET PROFIT(Q)

At CNY 6.87 MM has Fallen at -91.36%

OPERATING CASH FLOW(Y)

Lowest at CNY 47.17 MM

ROCE(HY)

Lowest at -25.72%

RAW MATERIAL COST(Y)

Grown by 22.91% (YoY

OPERATING PROFIT MARGIN(Q)

Lowest at 23.19 %

Here's what is working for Shanghai Hile Bio-Technology Co., Ltd.

Net Sales

At CNY 88.5 MM has Grown at 104.71%

over average net sales of the previous four periods of CNY 43.23 MM

MOJO Watch

Near term sales trend is extremely positive

Net Sales (CNY MM)

Net Sales

Highest at CNY 88.5 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 20.53 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Here's what is not working for Shanghai Hile Bio-Technology Co., Ltd.

Pre-Tax Profit

At CNY 13.04 MM has Fallen at -88.07%

over average net sales of the previous four periods of CNY 109.32 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 6.87 MM has Fallen at -91.36%

over average net sales of the previous four periods of CNY 79.58 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 0.86 MM has Grown at 11.91%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 47.17 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit Margin

Lowest at 23.19 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost

Grown by 22.91% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales